Buy AC-262 Accadrine SARM in Thailand
AC-262 Accadrine comes in a 30ml liquid bottle containing 10 mg per ml. The compound’s full development code is AC-262536, although it is usually shortened to AC-262 within the SARM market.
AC-262536 is an investigational selective androgen receptor modulator originally developed by Acadia Pharmaceuticals. It was researched for its tissue-selective interaction with androgen receptors and its potential anabolic activity in muscle.
AC-262 Product Specifications
| Product | AC-262 Accadrine |
|---|---|
| Full development code | AC-262536 |
| Concentration | 10 mg per ml |
| Bottle size | 30ml |
| Format | Liquid |
| Compound class | Investigational selective androgen receptor modulator |
What Is AC-262 Accadrine?
AC-262536 is a nonsteroidal SARM that acts as a partial agonist of the androgen receptor. It was designed to produce tissue-selective activity rather than the full androgen-receptor response associated with traditional androgenic compounds.
The compound is usually marketed as AC-262 or Accadrine. These names refer to AC-262536 and should not be confused with unrelated compounds that use similar research codes.
Selective Androgen Receptor Research
Early laboratory research found that AC-262536 bound selectively to the androgen receptor without significant affinity for the other receptors included in the study. This selectivity was a central part of its development as a novel SARM.
Researchers described AC-262536 as a partial androgen-receptor agonist, meaning it activated the receptor differently from a full agonist such as testosterone. This pharmacological profile helped distinguish AC-262536 from conventional steroidal androgens.
Anabolic Activity Research
In a two-week preclinical study, AC-262536 significantly improved anabolic measurements in androgen-deficient animal models. Researchers reported increased growth of androgen-responsive muscle tissue together with suppression of elevated luteinizing hormone levels.
The same research found substantially weaker activity in prostate and seminal-vesicle tissue than testosterone. The researchers concluded that AC-262536 demonstrated beneficial anabolic effects together with tissue-selective androgen-receptor activity.
Why AC-262 Is Known as Accadrine
Accadrine is the market name most commonly associated with AC-262536. Customers may encounter the compound listed as AC-262, AC-262536 or Accadrine, but all three names should identify the same SARM.
Interest in AC-262 is connected to its early research involving androgen-receptor selectivity, anabolic activity and comparatively weaker stimulation of certain androgen-sensitive tissues.
Research Status
Available published research on AC-262536 is primarily preclinical. The findings helped establish the compound’s SARM classification but do not guarantee a specific amount of muscle growth, strength improvement or body-composition change for an individual.
AC-262 and Tested Sport
AC-262536 falls within the selective androgen receptor modulator class prohibited under the World Anti-Doping Agency Prohibited List. Athletes subject to anti-doping rules should avoid exposure to Accadrine.
Independent Information Sources
- Pharmacological characterization of AC-262536
- PubChem information for AC-262536
- World Anti-Doping Agency Prohibited List
This page summarizes the product specifications and published AC-262536 research. Results are not guaranteed, and AC-262536 remains an investigational SARM.
